Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDT

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

April 25, 2023

Primary Completion Date

October 17, 2023

Study Completion Date

October 17, 2023

Conditions
Retinitis PigmentosaRetinal Dystrophy
Interventions
OTHER

Observational

"The goal of this observational study is to assess the reliability and validity of the multi-luminance Y-Mobility Test (MLYMT) and multi-luminance shape description test (MLSDT) for evaluation of subjects with severe vision impairment due to RP.~Normally sighted subjects will provide a control group. The MLYMT consists of two LED panels, one of which is illuminated at multiple luminance levels, positioned at the end of Y-configuration. Seven obstacles are placed ahead of the panels, which the test subject should detect and avoid before reaching and touching the lit panel."

Trial Locations (8)

33136

Nanoscope Clinical Site, Miami

58103

Nanoscope Clinical Site, Fargo

77401

Nanoscope Clinical Site, Bellaire

78240

Nanoscope Clincal Site, San Antonio

78503

Nanoscope Clinical Site, McAllen

85020

Nanoscope Clinical Site, Phoenix

90211

Nanoscope Clinical Site, Beverly Hills

00612

Nanoscope Clinical Site, Arecibo

Sponsors
All Listed Sponsors
lead

Nanoscope Therapeutics Inc.

INDUSTRY

NCT05820100 - Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDT | Biotech Hunter | Biotech Hunter